by Green Griffith | May 11, 2017 | Firm News
Green Griffith successfully asserted Horizon’s Orange-Book-listed U.S. Patent No. 9,066,913 covering its PENNSAID® 2% (topical diclofenac sodium) product in Hatch-Waxman litigation against generic challenger,...
by Green Griffith | Apr 26, 2017 | Firm News
Green Griffith scored a resounding trial victory for Dexcel Pharma Technologies Ltd. Dexcel sought a declaratory judgment that Dexcel’s FDA-approved over the counter (“OTC”) lansoprazole delayed-released orally disintegrating tablet (“ODT”) product did not infringe...
by Green Griffith | Sep 13, 2016 | Firm News
Green Griffith and Borg-Breen LLP is proud to announce that Robert F. Green has been recognized in the area of Hatch-Waxman Patent Litigation (Generic) in the 2017 edition of LMG Life Sciences. In addition, the firm was recommended in the area of Hatch-Waxman Patent...
by Green Griffith | Aug 14, 2016 | Firm News
Green Griffith and Borg-Breen is proud to announce that Robert F. Green has been selected for inclusion in the 2018 edition of The Best Lawyers in America© in the areas of Litigation-Intellectual Property and Patent Law. The Best Lawyers in America© is based on a...
